These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Differential sensitivity of CNS regions to acetylcholinesterase inhibition following chronic low-dose soman treatment in the rat. Howerton TC, Murphy MR, Miller SA, Hartgraves SL. Psychopharmacology (Berl); 1991; 105(3):400-6. PubMed ID: 1798835 [Abstract] [Full Text] [Related]
11. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice. Tripathi HL, Dewey WL. J Toxicol Environ Health; 1989; 26(4):437-46. PubMed ID: 2709438 [Abstract] [Full Text] [Related]
12. [Histochemical analysis of the multiple effect of organophosphorous compounds (Wolfatox, DFP) in rats (author's transl)]. Tòth L, Karcsú S, Marosi G, Simon Z. Acta Histochem; 1980; 66(2):220-33. PubMed ID: 6774581 [Abstract] [Full Text] [Related]
19. Cholinergic systems influence local cerebral glucose use in specific anatomical areas: diisopropyl phosphorofluoridate versus soman. Churchill L, Pazdernik TL, Cross RS, Giesler MP, Nelson SR, Samson FE. Neuroscience; 1987 Jan 07; 20(1):329-39. PubMed ID: 3561766 [Abstract] [Full Text] [Related]
20. Elevated choline levels in brain. A non-cholinergic component of organophosphate toxicity. Flynn CJ, Wecker L. Biochem Pharmacol; 1986 Sep 15; 35(18):3115-21. PubMed ID: 3753519 [Abstract] [Full Text] [Related] Page: [Next] [New Search]